unnamed

Welcome!

This course will improve your clinical expertise in the diagnosis and treatment of infertility, through restoring the health of your patients.

You will receive course access until February 2025, with the opportunity for 1:1 phone support from Nora Pope, FCP or Dr. Jessica Liu, ND for your extra questions on program content.

To begin, click on the first Start button in Part 1 below.  Resources, slide handouts and references can be downloaded from the “resources” section.

 
AAFP Credit Statement
Other CE/CEU Credits
Disclosures

The American Academy of Family Physicians (AAFP) has reviewed Cycle Charting, Progesterone HRT and Fertility Enhancement, as part of the Restorative Reproductive Medicine Self-Study Series, and deemed it acceptable for AAFP credit. Up to 7.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) may be claimed for the learning activity. Term of approval is from 06/01/2024 to 06/01/2025.

A certificate will be issued in your course portal after completion of all 3 lessons and quizzes, as well as the course feedback. AAFP is recognized by the AMA, ANCC, AOA, CFCP and several other professional healthcare bodies.

 

This course is also approved for CE/CME Credits with:

  • College of Naturopaths of Ontario (CONO): 6.0 Category A incl. 2.0 Pharmacy

  • College of Naturopathic Physicians of BC: 4.0 Category C & 2.0 Category F

  • College of Naturopathic Doctors of Alberta: 6.0 Competency Credits

  • CE Credits Recognized for Naturopathic Doctors in Manitoba, Saskatchewan, NB, NS, and PEI

  • Oregon Board of Naturopathic Medicine: 6.0 CE Credits incl. 2.0 Obstetrics & 2.0 Pharmacy

  • Vermont OPR of Naturopathic Physicians: 6.0 CE Credits incl. 2.0 Child Birthing & 2.0 Pharmacy

  • Washington State Department of Health Board of Naturopathy: 6.0 Category, including 2.0 Pharmacology

  • College of Pharmacists of BC: 6.0 CE Credits

  • Alberta College of Pharmacy: 6.0 CE Credits

  • For other Healthcare Professionals, please contact your regulatory board for more information.

Disclosures of Conflicts of Interest: Nora Pope FCP and Dr. Jessica Liu ND are the founders and owners of Fertility Continuing Education.

Disclosure of Unlabeled Use: This presentation includes a discussion of the off-label use of Naltrexone for women’s health conditions including endometriosis, dysmenorrhea, as well as infertility/sub-fertility.  Naltrexone is an FDA-approved opioid antagonist used to treat alcohol use disorder and opioid dependence but is not currently approved for the conditions discussed in this activity.

This presentation also will include a discussion of the off-label use of dextroamphetamine to treat dysmenorrhea, infertility, and miscarriage.  Dextroamphetamine has been FDA-approved for the treatment and management of Attention Deficit Hyperactivity Disorder (ADHD) and binge eating disorder (BED) but is not currently approved for the conditions discussed in this activity.

Course Curriculum

Start Next Lesson Presentation: Cycle Charting and Obstetrics